Skip to main content
. Author manuscript; available in PMC: 2021 Feb 10.
Published in final edited form as: Small. 2020 Jan 23;16(7):e1906360. doi: 10.1002/smll.201906360

Figure 1.

Figure 1.

Schematic showing that nanotherapeutics are associated with lower hepatotoxicity than their small molecule counterparts, and the description of the components and formulation of core-shell nanoparticles (NPs).